Stage IV Non-Small Cell Lung Cancer

Oncology
1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Acrotech Biopharma
Acrotech BiopharmaNJ - East Windsor
1 program
1
Belinostat, Carboplatin, PaclitaxelPhase 1/21 trial
Active Trials
NCT01310244CompletedEst. Aug 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Acrotech BiopharmaBelinostat, Carboplatin, Paclitaxel

Clinical Trials (1)

NCT01310244Acrotech BiopharmaBelinostat, Carboplatin, Paclitaxel

MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC

Start: Dec 2010Est. completion: Aug 2015
Phase 1/2Completed

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space